NFKB1 and metabolic dysfunction-associated steatotic liver disease: DSSG was effective for treating NAFLD patients, which could be attributed to increased activity of superoxide dismutase, a decrease of malondialdehyde as well as reduced NF‐κB activity in a NAFLD rat model.